KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Staar Surgical (STAA) Shares Outstanding (Weighted Average) (2021 - 2026)

Staar Surgical's Shares Outstanding (Weighted Average) history spans 12 years, with the latest figure at $49.6 million for Q1 2026.

  • For Q1 2026, Shares Outstanding (Weighted Average) rose 0.9% year-over-year to $49.6 million; the TTM value through Jan 2026 reached $49.6 million, up 0.9%, while the annual FY2026 figure was $49.6 million, 0.9% up from the prior year.
  • Shares Outstanding (Weighted Average) reached $49.6 million in Q1 2026 per STAA's latest filing, roughly flat from $49.6 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $49.6 million in Q3 2025 to a low of $47.8 million in Q2 2022.
  • Average Shares Outstanding (Weighted Average) over 5 years is $48.7 million, with a median of $48.8 million recorded in 2023.
  • Peak YoY movement for Shares Outstanding (Weighted Average): grew 1.65% in 2022, then grew 0.8% in 2025.
  • A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $48.0 million in 2022, then increased by 1.12% to $48.5 million in 2023, then rose by 1.24% to $49.1 million in 2024, then rose by 1.03% to $49.6 million in 2025, then fell by 0.13% to $49.6 million in 2026.
  • Per Business Quant, the three most recent readings for STAA's Shares Outstanding (Weighted Average) are $49.6 million (Q1 2026), $49.6 million (Q3 2025), and $49.5 million (Q2 2025).